1. Autosomal dominant polycystic kidney disease. Issue 10174 (2nd March 2019) Authors: Cornec-Le Gall, Emilie; Alam, Ahsan; Perrone, Ronald D Journal: Lancet Issue: Volume 393:Issue 10174(2019) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identifying patient‐important outcomes in polycystic kidney disease: An international nominal group technique study. Issue 12 (2nd May 2019) Authors: Cho, Yeoungjee; Sautenet, Benedicte; Gutman, Talia; Rangan, Gopala; Craig, Jonathan C; Ong, Albert C; Chapman, Arlene; Ahn, Curie; Coolican, Helen; Kao, Juliana T‐W; Gansevoort, Ron; Perrone, Ronald D; Harris, Tess; Torres, Vicente; Pei, York; Kerr, Peter G; Ryan, Jessica; Johnson, David W; Viece... Journal: Nephrology Issue: Volume 24:Issue 12(2019) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. (31st March 2017) Authors: Torres, Vicente E; Chapman, Arlene B; Devuyst, Olivier; Gansevoort, Ron T; Perrone, Ronald D; Dandurand, Ann; Ouyang, John; Czerwiec, Frank S; Blais, Jaime D Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 3 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗